Evaluation of Modest LDH Elevation in Post‑partum Women with Hepatic and Bone Abnormalities

Interpretation of Hepatic Enzyme Patterns

An ALT/AST ratio of approximately 2 : 1 (e.g., 118 U/L vs 60 U/L) points to a hepatocellular pattern of injury that is typical of metabolic, drug‑induced, or autoimmune hepatitis rather than malignant infiltration. 1
A concurrent rise in GGT (≈ 84 U/L) together with an elevated total ALP (≈ 371 U/L) indicates that a substantial portion of the ALP originates from the liver, because GGT reliably discriminates hepatic from bone sources of ALP. 3
When total ALP is disproportionately high relative to transaminases, a significant bone contribution should be suspected, especially in the setting of severe osteoporosis (Z‑score ≈ ‑3) and active post‑partum bone remodeling. 3

Lactate dehydrogenase (LDH) is a highly nonspecific marker that rises in virtually any condition causing cellular lysis or injury, including intense exercise, liver disease, myocardial infarction, renal disease, hemolysis, and pneumonia. 4
An LDH value of 266 U/L represents a minimal increase (generally < 1.5 × the upper limit of normal) and does not provide diagnostic evidence for cancer when no histologically confirmed metastatic germ‑cell tumor is present. [5][4]
In oncology, LDH is useful only as a prognostic indicator for already‑confirmed metastatic germ‑cell tumors, where levels > 10 × the upper limit of normal define a high‑risk group. 5

Suppressed TSH (≈ 0.1 µIU/mL) with normal free T4 in the post‑partum period suggests either postpartum thyroiditis in its hyper‑thyroid phase or Graves disease; both conditions can cause elevations of hepatic enzymes. [6][7]
Hyperthyroidism can directly increase transaminases and LDH by accelerating cellular metabolism and promoting cell lysis. 6

Active bone remodeling associated with severe osteoporosis and the post‑partum state raises bone‑derived ALP, contributing markedly to the total ALP measurement of ≈ 371 U/L. 3
Hormonal and metabolic shifts in the post‑partum period can produce transient, benign elevations of liver tests even in otherwise healthy women. 7

Perform comprehensive viral serologies (HBV, HCV, HAV, HEV) to rule out infectious hepatitis. 8
Order an autoimmune liver panel (ANA, ASMA, ANCA, AMA, quantitative IgG/IgM/IgA) to exclude autoimmune hepatitis. 8
Review all medications, supplements, and herbal products to identify possible drug‑induced hepatotoxicity. 8

Measure bone‑specific ALP to determine the proportion of ALP derived from skeletal turnover. 3

Test for TSH‑receptor antibodies (TRAb) to differentiate Graves disease (TRAb‑positive) from postpartum thyroiditis (TRAb‑negative). [6][7]
Assess anti‑TPO and anti‑thyroglobulin antibodies to confirm autoimmune thyroiditis. 7

Use abdominal ultrasound with Doppler as the first‑line imaging modality when cytolysis persists or worsens after exclusion of other causes. 8
Routine imaging is not indicated initially because the biochemical profile can be fully explained by identified benign conditions. [1][8]

Do not interpret a modestly elevated LDH as a sign of malignancy in the absence of a detectable tumor mass. 4
Do not overlook hyperthyroidism as a reversible cause of elevated liver enzymes and LDH; appropriate thyroid treatment often normalizes hepatic labs. 6
Do not assume that an elevated ALP is solely hepatic when both GGT is high and severe osteoporosis is present; a dual hepatic‑and‑bone origin is common in this scenario. 3